Comments

GRI Bio Stock Price, Quotes and Forecasts

Q: What sector and industry does GRI Bio (GRI) operate in?

GRI Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

GRINASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$1.50

0.053.45%

At close: -

$1.49

-0.01-0.67%

After Hours: May 16, 7:41 PM EDT

Q1 2025 Earnings were released on Thu May 15th, before the market open

GRI Bio (GRI) Forecast

News Earnings GRI Bio (GRI) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

GRI Bio Stock Price, Quotes and Forecasts | NASDAQ:GRI | Benzinga

Explore GRI Bio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GRI.

Open	$1.45
Close	$1.50
Volume / Avg.	120.88K / 399.39K
Day Range	$1.40 - $1.51
52 Wk Range	1.10 - 106.04
Market Cap	$1.08M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	14.88%
Days to Cover	1

Recent News

Why Is Nano Cap GRI Bio Stock Skyrocketing On Tuesday?

GRI Bio reported interim Phase 2a results for GRI-0621 in IPF, showing safety and no significant cholesterol changes.

Vandana Singh

Dow Falls Over 150 Points; General Motors Tops Q3 Views

Avi Kapoor

Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.45
Close	$1.50
Volume / Avg.	120.88K / 399.39K
Day Range	$1.40 - $1.51
52 Wk Range	1.10 - 106.04
Market Cap	$1.08M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	14.88%
Days to Cover	1

About GRI Bio Inc

Sector

Health Care

Industry

Biotechnology

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy GRI Bio (GRI) stock?

You can purchase shares of GRI Bio (NASDAQ:GRI) through any online brokerage.

View our list of the best stock brokerages

Who are GRI Bio (GRI) competitors?

Other companies in GRI Bio’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Polyrizon (NASDAQ:PLRZ), Entero Therapeutics (NASDAQ:ENTO), Shuttle Pharmaceuticals (NASDAQ:SHPH) and NuCana (NASDAQ:NCNA).

What is the forecast, or price target, for GRI Bio (GRI) stock?

GRI Bio has a consensus price target of $11.50.

What is the current price for GRI Bio (GRI)?

The stock price for GRI Bio (NASDAQ: GRI) is $1.49 last updated May 16, 2025 at 7:41 PM EDT.

Does GRI Bio (GRI) pay a dividend?

A quarterly cash dividend of 0.51 per share of Class A Common Stock. The quarterly cash dividend was payable on December 27, 2019 to stockholders of record on December 19, 2019.

When is GRI Bio (NASDAQ:GRI) reporting earnings?

GRI Bio’s Q2 earnings are confirmed for Wednesday, August 13, 2025.

Is GRI Bio (GRI) going to split?

There is no upcoming split for GRI Bio.

What sector and industry does GRI Bio (GRI) operate in?

GRI Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.